Comparison of Chikungunya Virus-Induced Disease Progression and Pathogenesis in Type-I Interferon Receptor-Deficient Mice (A129) and Two Wild-Type (129Sv/Ev and C57BL/6) Mouse Strains.

Autor: Graham VA; UK Health Security Agency (UKHSA), Porton Down, Salisbury SP4 0JG, Wiltshire, UK., Easterbrook L; UK Health Security Agency (UKHSA), Porton Down, Salisbury SP4 0JG, Wiltshire, UK., Rayner E; UK Health Security Agency (UKHSA), Porton Down, Salisbury SP4 0JG, Wiltshire, UK., Findlay-Wilson S; UK Health Security Agency (UKHSA), Porton Down, Salisbury SP4 0JG, Wiltshire, UK., Flett L; UK Health Security Agency (UKHSA), Porton Down, Salisbury SP4 0JG, Wiltshire, UK., Kennedy E; UK Health Security Agency (UKHSA), Porton Down, Salisbury SP4 0JG, Wiltshire, UK., Fotheringham S; UK Health Security Agency (UKHSA), Porton Down, Salisbury SP4 0JG, Wiltshire, UK., Kempster S; Medicines and Healthcare Products Regulatory Agency (MHRA), Blanche Ln, South Mimms, Potters Bar EN6 3QG, Hertfordshire, UK., Almond N; Medicines and Healthcare Products Regulatory Agency (MHRA), Blanche Ln, South Mimms, Potters Bar EN6 3QG, Hertfordshire, UK., Dowall S; UK Health Security Agency (UKHSA), Porton Down, Salisbury SP4 0JG, Wiltshire, UK.

Publikováno v: Viruses [Viruses] 2024 Sep 27; Vol. 16 (10). Date of Electronic Publication: 2024 Sep 27.

Convalescent human plasma candidate reference materials protect against Crimean-Congo haemorrhagic fever virus (CCHFV) challenge in an A129 mouse model.

Autor: Kempster S; Science Research and Innovation, Medicines and Healthcare products Regulatory Agency, Blanche Lane, South Mimms, EN6 3QG, UK. Electronic address: sarah.kempster@mhra.gov.uk., Hassall M; Science Research and Innovation, Medicines and Healthcare products Regulatory Agency, Blanche Lane, South Mimms, EN6 3QG, UK., Graham V; Virology & Pathogenesis group, UK Health Security Agency, Manor Farm Rd, Porton Down, Salisbury SP4 0JG, UK., Kennedy E; Virology & Pathogenesis group, UK Health Security Agency, Manor Farm Rd, Porton Down, Salisbury SP4 0JG, UK., Findlay-Wilson S; Virology & Pathogenesis group, UK Health Security Agency, Manor Farm Rd, Porton Down, Salisbury SP4 0JG, UK., Salguero FJ; Virology & Pathogenesis group, UK Health Security Agency, Manor Farm Rd, Porton Down, Salisbury SP4 0JG, UK., Bagci B; Sivas Cumhuriyet University, Sivas, Turkey., Elaldi N; Sivas Cumhuriyet University, Sivas, Turkey., Oz M; Sivas Cumhuriyet University, Sivas, Turkey., Tasseten T; Sivas Cumhuriyet University, Sivas, Turkey., Charlton FW; School of Molecular and Cellular Biology, Faculty of Biological Sciences, University of Leeds, Woodhouse Lane, Leeds, LS2 9JT, UK; Astbury Centre, Astbury Centre for Structural Molecular Biology, University of Leeds, Woodhouse Lane, Leeds, LS2 9JT, UK; Current address: Supramolecular nanomaterials and interfaces laboratory (SuNMIL), École Polytechnique Fédérale de Lausanne, Switzerland., Barr JN; School of Molecular and Cellular Biology, Faculty of Biological Sciences, University of Leeds, Woodhouse Lane, Leeds, LS2 9JT, UK; Astbury Centre, Astbury Centre for Structural Molecular Biology, University of Leeds, Woodhouse Lane, Leeds, LS2 9JT, UK., Fontana J; School of Molecular and Cellular Biology, Faculty of Biological Sciences, University of Leeds, Woodhouse Lane, Leeds, LS2 9JT, UK; Astbury Centre, Astbury Centre for Structural Molecular Biology, University of Leeds, Woodhouse Lane, Leeds, LS2 9JT, UK., Duru C; Science Research and Innovation, Medicines and Healthcare products Regulatory Agency, Blanche Lane, South Mimms, EN6 3QG, UK., Ezeajughi E; Science Research and Innovation, Medicines and Healthcare products Regulatory Agency, Blanche Lane, South Mimms, EN6 3QG, UK., Matejtschuk P; Science Research and Innovation, Medicines and Healthcare products Regulatory Agency, Blanche Lane, South Mimms, EN6 3QG, UK., Arnold U; High Containment Microbiology and Imaging, UKHSA, 61 Colindale Avenue, London, NW9 5EQ, UK., Adedeji Y; Science Research and Innovation, Medicines and Healthcare products Regulatory Agency, Blanche Lane, South Mimms, EN6 3QG, UK., Mirazimi A; Public Health Agency of Sweden, Solna, Sweden; Division of Clinical Microbiology, Department of Laboratory Medicine, Karolinska Institute, ANA Futura, Campus Flemingsberg, Stockholm, Sweden., Hewson R; Virology & Pathogenesis group, UK Health Security Agency, Manor Farm Rd, Porton Down, Salisbury SP4 0JG, UK; Faculty of Infectious and Tropical Diseases, London School of Hygiene and Tropical Medicine, London WC1E 7HT, United Kingdom., Dowall S; Virology & Pathogenesis group, UK Health Security Agency, Manor Farm Rd, Porton Down, Salisbury SP4 0JG, UK., Almond N; Science Research and Innovation, Medicines and Healthcare products Regulatory Agency, Blanche Lane, South Mimms, EN6 3QG, UK.

Publikováno v: Virus research [Virus Res] 2024 Aug; Vol. 346, pp. 199409. Date of Electronic Publication: 2024 Jun 01.

Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.

Becoming a leader: a co-produced autoethnographic exploration of situated learning of leadership practice

Autor: Kempster, S.

Publikováno v: Development and Learning in Organizations: An International Journal, 2010, Vol. 24, Issue 5.

Externí odkaz: http://www.emeraldinsight.com/doi/10.1108/dlo.2010.08124ead.008

Intrinsic host susceptibility among multiple species to intranasal SARS-CoV-2 identifies diverse virological, biodistribution and pathological outcomes.

Autor: Berry N; Division of Infectious Disease Diagnostics, NIBSC, Hertfordshire, UK. neil.berry@nibsc.org., Ferguson D; Division of Infectious Disease Diagnostics, NIBSC, Hertfordshire, UK., Kempster S; Division of Infectious Disease Diagnostics, NIBSC, Hertfordshire, UK., Hall J; Division of Infectious Disease Diagnostics, NIBSC, Hertfordshire, UK., Ham C; Division of Infectious Disease Diagnostics, NIBSC, Hertfordshire, UK., Jenkins A; Division of Infectious Disease Diagnostics, NIBSC, Hertfordshire, UK., Rannow V; Division of Analytical and Biological Sciences, NIBSC, Hertfordshire, UK., Giles E; Division of Analytical and Biological Sciences, NIBSC, Hertfordshire, UK., Leahy R; Division of Analytical and Biological Sciences, NIBSC, Hertfordshire, UK., Goulding S; Division of Analytical and Biological Sciences, NIBSC, Hertfordshire, UK., Fernandez A; Division of Analytical and Biological Sciences, NIBSC, Hertfordshire, UK., Adedeji Y; Division of Virology, NIBSC, Hertfordshire, UK., Vessillier S; Division of Biotherapeutics, NIBSC, Hertfordshire, UK., Rajagopal D; Division of Biotherapeutics, NIBSC, Hertfordshire, UK., Prior S; Division of Biotherapeutics, NIBSC, Hertfordshire, UK., Le Duff Y; Division of Infectious Disease Diagnostics, NIBSC, Hertfordshire, UK., Hurley M; Division of Infectious Disease Diagnostics, NIBSC, Hertfordshire, UK., Gilbert S; Division of Infectious Disease Diagnostics, NIBSC, Hertfordshire, UK., Fritzsche M; Division of Analytical and Biological Sciences, NIBSC, Hertfordshire, UK., Mate R; Division of Analytical and Biological Sciences, NIBSC, Hertfordshire, UK., Rose N; Division of Virology, NIBSC, Hertfordshire, UK., Francis RJ; Division of Analytical and Biological Sciences, NIBSC, Hertfordshire, UK., MacLellan-Gibson K; Division of Analytical and Biological Sciences, NIBSC, Hertfordshire, UK., Suarez-Bonnet A; Department of Pathobiology and Population Sciences, The Royal Veterinary College, Hertfordshire, UK., Priestnall S; Department of Pathobiology and Population Sciences, The Royal Veterinary College, Hertfordshire, UK., Almond N; Division of Infectious Disease Diagnostics, NIBSC, Hertfordshire, UK. neil.almond@nibsc.org.

Publikováno v: Scientific reports [Sci Rep] 2022 Nov 04; Vol. 12 (1), pp. 18694. Date of Electronic Publication: 2022 Nov 04.